Cells.CD4.Tumor necrosis factor alfa-expressing/Cells.CD4 after stimulation with SARS-CoV-2 Nucleocapsid peptide:NFr:Pt:Bld:Qn:

Preferred Label : Cells.CD4.Tumor necrosis factor alfa-expressing/Cells.CD4 after stimulation with SARS-CoV-2 Nucleocapsid peptide:NFr:Pt:Bld:Qn:;

LOINC status : TRIAL;

LOINC display name : Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells after stimulation with SARS-CoV-2 Nucleocapsid peptide (Bld);

LOINC long common name : Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide;

LOINC short name : CD4 TNFa/CD4 p COVID NuclCap;

Details

Origin ID

100863-0;

UMLS CUI

C5689533;

Has challenge
- after stimulation with SARS-CoV-2 Nucleocapsid peptide [LOINC Challenge]
Has component
- CD4 [LOINC component]
- CD4 cells [LOINC component]
- Cells [LOINC component]
- Cells.CD4.Tumor necrosis factor alfa-expressing [LOINC component]
- Cells.CD4.Tumor necrosis factor alfa-expressing/Cells.CD4 [LOINC component]
- Cells.CD4.Tumor necrosis factor alfa-expressing/Cells.CD4^after stimulation with SARS-CoV-2 Nucleocapsid peptide [LOINC component]
- SARS-CoV-2 [LOINC component]
- Tumor necrosis factor [LOINC component]
Has property
- Number Fraction [LOINC Property]
Has system
- Blood [LOINC System]
Has time aspect
- Point in time (spot) [LOINC time aspect]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients